{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atheroma", "query": { "condition": "Atheroma" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 12, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Atheroma&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T09:44:01.886Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00853827", "title": "Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Disease (CAD)", "Coronary Atherosclerosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aliskiren", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 613, "start_date": "2009-03", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2014-06-03", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 54, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 48 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853827" }, { "nct_id": "NCT02389894", "title": "Neuroprotection in Patients Undergoing Aortic Valve Replacement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aortic Stenosis", "Brain Infarction", "Cerebrovascular Accident", "Stroke" ], "interventions": [ { "name": "Embol-X Embolic Protection Device", "type": "DEVICE" }, { "name": "CardioGard Cannula", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 383, "start_date": "2015-03", "completion_date": "2017-01", "has_results": true, "last_update_posted_date": "2019-04-29", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 14, "location_summary": "Los Angeles, California • Atlanta, Georgia • Baltimore, Maryland + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT02389894" }, { "nct_id": "NCT05838547", "title": "CANF-Comb-II PET-MR in Atherosclerosis Multisite", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Carotid Atherosclerosis", "Asymptomatic Carotid Artery Stenosis", "Carotid Artery Atheroma" ], "interventions": [ { "name": "64Cu-25%-CANF-Comb", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2023-03-21", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-03-23", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 2, "location_summary": "Los Angeles, California • St Louis, Missouri", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05838547" }, { "nct_id": "NCT00640744", "title": "Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 12, "start_date": "2006-02", "completion_date": "2010-02", "has_results": false, "last_update_posted_date": "2010-12-07", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00640744" }, { "nct_id": "NCT00240318", "title": "A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Arteriosclerosis" ], "interventions": [ { "name": "Rosuvastatin calcium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2002-11", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2010-11-19", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Stockton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00240318" }, { "nct_id": "NCT00590616", "title": "Utility of Clinical Examination in the Noninvasive Prediction of Aortic Atheroma - A Prospective Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "transthoracic examination", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Creighton University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 125, "start_date": "2005-02", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2014-08-12", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT00590616" }, { "nct_id": "NCT00116831", "title": "Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "Glipizide", "type": "DRUG" }, { "name": "rosiglitazone maleate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "30 Years to 80 Years" }, "enrollment_count": 672, "start_date": "2005-01", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2017-03-23", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00116831" }, { "nct_id": "NCT01248143", "title": "Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Assess the Effect of Green Tea on Diabetes", "Assess the Effect of Fermented Papaya Pretration on Diabetes", "Effects of Green Tea and FPP on C-reactive Proteins", "Effects of Green Tea and FPP of Lipid Profiles in Diabetes", "Effect of Green Tea and FPP on Atheroma Formation" ], "interventions": [ { "name": "Green tea", "type": "DIETARY_SUPPLEMENT" }, { "name": "FPP", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "The Touro College and University System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "35 Years to 65 Years" }, "enrollment_count": 300, "start_date": "2010-11", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2014-11-17", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01248143" }, { "nct_id": "NCT00343655", "title": "Evaluation of Atorvastatin Treatment on Carotid Plaque.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Diseases" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 160, "start_date": "2007-01", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00343655" }, { "nct_id": "NCT03897478", "title": "Biomarkers of Acute Stroke in Clinic", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ischemic Stroke", "Ischemia", "Atrial Fibrillation", "Transient Ischemic Attack", "Transient Cerebrovascular Events", "Thrombotic Stroke", "Stroke", "Stroke, Acute", "Stroke, Ischemic", "Stroke, Complication", "Stroke of Basilar Artery", "Atherosclerosis", "Atheroma", "Cardioembolic Stroke", "Cardiomyopathies", "Cardiovascular Stroke", "Thromboembolism" ], "interventions": [ { "name": "ISCDX blood test", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Ischemia Care LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 500, "start_date": "2019-04-01", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-05-22T09:44:01.886Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03897478" } ] }